Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Top 10

BioSapien

3D-printed biodegradable MediChip implant delivering chemotherapy locally at the tumour site, now in colorectal cancer trials in the UAE.

Open the dossier
Opportunities
4
High confidence
070% and above
Counterparts
4startups and investors
  • Customers 1
  • Co-development 2
  • Investors 1

Customers1

Who could buy, or sell through

Buy oncology real-world data to design the next trial

BioSapien must choose indications, endpoints and sites for its next trials. Cromodata sells de-identified, standardised oncology and imaging datasets from a network of hospitals in five Latin American countries, which can inform recurrence rates and control-arm assumptions and identify candidate trial sites outside the UAE.

30%confidence

Evidence from the records

  • “Clinical trials in colorectal cancer are being conducted in the United Arab Emirates.”
  • “Pipeline for de-identifying and standardizing fragmented clinical records (imaging, oncology) into usable datasets, with secure access.”
If it works
Better-powered trial design and a shortlist of Latin American sites; a named pharma-grade data buyer for Cromodata.
First step
Send Cromodata a data request for colorectal cancer cohorts (surgery, recurrence, chemotherapy regimens) and request a sample dictionary.

Co-development2

An integration or joint product

Polymer platform partnership for next-generation implants

MediChip's performance depends on polymer degradation and release kinetics; Pleryon has proprietary platforms to design and control large synthetic and modified natural polymers for drug delivery and injectable biomaterials. A material-supply or joint-development agreement could extend MediChip's release window or open injectable formats, while giving Pleryon an oncology application outside ophthalmology.

30%confidence

Evidence from the records

  • “3D-printed, biodegradable, slow-release implant that can be attached to any tissue”
  • “Proprietary platforms for designing and controlling the structure of large synthetic and modified natural polymers, for drug delivery and injectable biomaterials.”
If it works
A jointly owned next-generation MediChip formulation and a stronger IP position for both companies.
First step
Hold a CSO-to-CSO call to compare polymer requirements (degradation time, drug loading) against Pleryon's catalogue.

Simulate implant release kinetics before printing

Each formulation iteration of an implant costs months of bench work. Caldera Engine couples physics simulation of macromolecular suspensions with AI to predict material properties; applied to MediChip's polymer-drug matrix it could narrow formulation candidates before wet-lab testing.

20%confidence

Evidence from the records

  • “slow-release implant”
  • “Caldera Engine: physics simulation of macromolecular suspensions coupled with AI to predict material properties.”
If it works
Shorter formulation cycles for MediChip variants and a first published life-science customer for Monte Caldera.
First step
Request a Caldera Engine trial and share one non-confidential polymer formulation for a feasibility simulation.

Investors1

A fund whose thesis fits

Approach a science-first VC for the Series A

BioSapien's next round must fund clinical progress; Breakout backs founders pairing technology with science at Seed and Series A and has a US focus consistent with BioSapien's NSF-funded R&D and Silicon Valley regional win. Breakout led ZymoChem's Series A, offering a warm introduction inside the network.

30%confidence

Evidence from the records

  • “Backs founders pairing technology with science (drug discovery, climate, neurotech, lab automation).”
  • “Breakout Ventures (lead), lululemon, Toyota Ventures, GS Futures, KdT Ventures, Cavallo Ventures”
  • “grant (NSF)”
If it works
A US science-focused co-investor that would de-risk an FDA pathway for MediChip.
First step
Ask ZymoChem's CEO for an introduction to the Breakout partner on his board, with a two-page clinical plan attached.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Most promising across the network

587 opportunities analysed
  1. BelliwithGolden Gate VenturesInvestors

    Pitch Series A to an Asia–Middle East early-stage VC

    Belli's revenue base sits exactly in Golden Gate's footprint: Singapore HQ, Southeast Asian carriers and Gulf flag carriers. Golden Gate invests Seed to Series A, the stage Belli is approaching, and already backed BioSapien in the network, which gives a warm founder-to-founder introduction.

    50%
  2. PraxilabswithMaria EducaçãoDistribution

    Embed PraxiLabs experiments into Maria Educação's learning paths in Brazil

    Maria Educação already sits inside Brazilian publishers, school networks and 80+ municipalities with an AI diagnostic that prescribes learning paths; it lacks a hands-on science layer. Plugging PraxiLabs simulations as prescribed activities gives PraxiLabs a paid B2B2G channel into Brazil and gives Maria Educação a differentiating STEM remediation module.

    50%
  3. VenditekwithPulster.aiCo-development

    Use Pulster NOVA to place and price every new machine

    Vending profitability is a location game, and Pulster sells site assessment and cannibalisation models to 49 Latin American retail brands from the same country. Venditek gets data-driven placement; Pulster gets a new micro-format use case and a joint offer to its retail clients.

    50%
  4. ORA TechnologieswithPwn&PatchCustomers

    Buy continuous threat-exposure management for the payments stack

    A payment super-app is a prime target for fraud and intrusion, and regulators expect continuous security testing. Pwn&Patch, a North African offensive-security firm with a CTEM platform, can cover attack-surface monitoring and continuous pentesting in French/Arabic, at regional cost. ORA reduces regulatory and breach risk; Pwn&Patch wins a flagship fintech reference in Morocco.

    50%
  5. Piezo Sonic CorporationwithProxima RoboticsCo-development

    Run Proxima Compass on Mighty AMR

    Piezo Sonic's differentiation is the rough-terrain chassis and drive, not fleet software; Proxima sells a hardware-agnostic navigation and flow-management layer to robot makers. Bundling Compass on Mighty AMR gives Piezo a proven European navigation stack and gives Proxima an outdoor, all-terrain reference platform beyond indoor AGVs.

    50%
  6. PraxilabswithKetzaiDistribution

    Insert virtual labs into Ketzai's AI-generated lesson plans

    Ketzai generates curriculum-aligned lesson plans for a large teacher base in Central America and the Caribbean; inserting PraxiLabs experiments as one-click activities converts lesson planning into lab usage. PraxiLabs gains Spanish-speaking teacher acquisition at near-zero CAC; Ketzai gains a premium content upsell.

    45%
  7. Proxima RoboticswithPiezo Sonic CorporationCo-development

    Port Compass to Piezo Sonic's all-terrain AMR

    Piezo Sonic builds rough-terrain AMRs and sells through Japanese trading houses; Proxima sells navigation software. A port opens outdoor robotics and an Asian channel for Proxima.

    45%
  8. Pwn&PatchwithORA TechnologiesCustomers

    Win ORA's super-app as a flagship fintech client

    ORA's payment super-app is exposed to regulatory and fraud risk and has no documented security partner. A continuous testing contract gives Pwn&Patch a Moroccan reference in fintech.

    45%
  9. UnitSensewithOrbisCustomers

    Cut Orbis's triple-model interview cost

    Orbis scores every interview with three independent AI models voting by majority, which multiplies inference cost per candidate in a price-sensitive SME market (Jordan, GCC, Egypt). UnitSense's per-request attribution and cheapest-good-enough routing directly targets that cost structure and gives Orbis a per-customer margin view.

    45%
  10. GreenirrwithAZ ShipDistribution

    Embed an emissions module in AZ Ship's TMS for Brazilian agri-shippers

    AZ Ship's TMS already centralises loads, carriers and delivery proofs for global agri-commodity shippers who carry Scope 3 targets. Adding Greenirr's per-shipment emissions calculation turns existing TMS data into reportable carbon figures; AZ Ship gains an ESG upsell and Greenirr a first international, channel-led market.

    45%
  11. AstrolightwithSeraphim SpaceInvestors

    Series A from a specialist space investor

    Seraphim invests globally in space and deep tech addressing security and resilience, from Seed onwards, and appears among G-Space's investors in the network. Astrolight's dual-use optical links fit that thesis precisely.

    40%
  12. ChonexwithCavallo VenturesInvestors

    Bring an agri CVC into the Series A

    Cavallo Ventures is an agri-focused CVC investing from seed to Series B and backed network member ZymoChem. A strategic agri investor fits Chonex's $6M Series A and can accelerate distribution.

    40%
  13. CredncewithMicrotractionInvestors

    Pitch a pre-seed fund whose ticket matches the round

    Crednce is raising $175,000; Microtraction writes $0.1–0.35M pre-seed tickets in Africa with FinTech in its sectors and Ghana in its geographies. The ticket and stage fit are exact, which is rare for a pre-traction fintech.

    40%
  14. TausiwithHairCoSys LimitedDistribution

    Distribute AI scalp analysis to Tausi's beauticians

    HairCoSys sells AI hair and scalp analysis tools used by Hong Kong salons. Tausi's beauticians could offer diagnostics as a premium service, making the AI claim concrete and opening Africa for HairCoSys.

    40%
  15. TERAMED SISTEMAS DE SAÚDE, SAwithTIBOKCustomers

    License TIBOK as a white-label engine for Baika

    Instead of building its own stack, Teramed could run Baika+Saúde on TIBOK's white-label OS (own brand, WhatsApp and phone numbers, Portuguese workspace) with pay-per-consultation pricing. It accelerates launch and reduces capex; TIBOK gains an Angolan distributor.

    40%
  16. TerraSparkwithSeraphim SpaceInvestors

    Target Seraphim Space for the seed round

    Seraphim invests globally in space and climate deep tech from seed onward, with a resilience thesis that covers energy security. It backed network member G-Space, giving a warm path to a seed lead after the 2026 demonstration.

    40%
  17. Thistle OÜwithOmniLoc AICo-development

    Integrate GPS-free localisation into Thistle Shield

    Counter-drone engagements happen where GPS is jammed or spoofed, often by the defender itself. OmniLoc's camera-to-satellite matching keeps autonomous platforms positioned without GPS, a direct building block for Thistle's autonomy and a field deployment for OmniLoc.

    40%
  18. Thistle OÜwithNATO DIANAInvestors

    Apply to NATO DIANA with the trial results

    NATO DIANA supports pre-seed and seed dual-use start-ups across Europe and North America, exactly Thistle's stage. Network member Astrolight is in the DIANA programme and can coach the application.

    40%
  19. TIBOKwithTERAMED SISTEMAS DE SAÚDE, SAMarket entry

    Power Teramed’s Angolan teleconsultation and corporate health offer as white-label

    Teramed holds the local positioning in Angola (corporate health, 24/7 GP teleconsultation, hospital booking) but shows no traction or disclosed technology depth; TIBOK offers exactly the white-label OS model already signed with C-Care. Teramed would become a Portuguese-speaking distributor, opening Angola without TIBOK building a local entity.

    40%
  20. EqorewithPolyJouleCustomers

    Deploy non-flammable polymer batteries at sensitive sites

    Some industrial sites have strict fire codes; PolyJoule's non-flammable, UL9540A-certified polymer batteries suit them. Eqore gains a differentiated product, PolyJoule a deployment channel.

    40%

Similar profiles

Compatibility score with BioSapien

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.